不恰当停用核苷类药物后导致重型肝炎的分析

朱玉成; 高玉金; 闫家徽

不恰当停用核苷类药物后导致重型肝炎的分析

徐州市传染病医院ICU

详细信息

中图分类号: R512.62
计量
- 文章访问数: 4036
- HTML全文浏览量: 16
- PDF下载量: 818
- 被引次数: 0
出版历程
- 出版日期: 2010-06-20

Severe hepatitis resulted from inappropriate use of nucleoside drugs

摘要

摘要: 目的回顾性分析核苷类药物不恰当停用后导致重型肝炎的临床表现、治疗及预后,采取相应的预防措施及处理方法。方法病例选择近四年来我院肝病科收治不恰当停用核苷类药物后导致重型肝炎41例患者,其中肝炎25例,肝硬化16例,予保肝、抗病毒、支持、人工肝等治疗,观察两组患者入院前的TBil、Alb、PTA、HBVDNA、并发症、预后差别。结果肝硬化组患者Alb、PTA、HBVDNA低,常见并发症:水电解质失衡、原发性腹膜炎、肝性脑病多见,病死率高,预后较差;肝炎患者预后相对较好。结论使用核苷类药物患者应加强交流、监督、随访,核苷类药物不恰当停用后应尽快服用高效、快速的抗病毒药物。
- 肝炎,病毒性,人 /
- 核苷类
Abstract: Objective To investigate the clinical manifestation, treatment and prognosis of severe hepatitis resulted from the inappropriate usage of nucleoside drugs.Methods A total of 41 cases of severe hepatitis resulted from the inappropriate usage of nucleoside drugs were detected from 2006 to 2010 (25 cases of hepatitis and 16 cases of liver cirrhosis) .The patients were treated with protecting liver, anti-virus and supportive artificial liver.The value of TBil, Alb, PTA, HBV DNA, common complications and the prognosis were compared.Results The values of Alb, PTA and HBV DNA were found to be lower.Common complications such as water electrolyte imbalance, primary peritonitis and brain disorder were more common.The mortality rate was higher and the prognosis was worse in liver cirrhosis group compared to the hepatitis group.Conclusion Strengthening patient monitoring and follow-up, prescribing highly effective anti viral drugs as soon as possible after the inappropriate usage of nucleoside drugs is important to avoid severe hepatitis.
- hepatitis /
- viral

HTML全文

参考文献(10)

[1]斯崇文.核苷类似物抗乙型肝炎病毒治疗的新进展[J].中华传染病杂志, 2005, 23 (Suppl1) ∶11-16.

[2]张斌, 董培玲, 丁惠国, 等.阿德福韦酯停用后致急性肝功能衰竭死亡[J].药物不良反应杂志, 2008, 10 (4) ∶289-290.

[3]中华医学会.病毒性肝炎防治方案[J].中华肝脏杂志, 2000, 8 (6) ∶324-329.

[4]中华医学会.肝衰竭诊疗指南[J].实用肝脏病杂志, 2006, 9 (6) ∶321-324.

[5]中华医学会.慢性乙型肝炎防治指南[J].胃肠病学, 2006, 11 (9) ∶550-557.

[6]Song BC, Suh DJ, Lee HC, et al.Hepatitis B e antigen serocon version after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea[J].Hepatology, 2000, 32 (4) ∶803-806.

[7]吴东刚, 冯岚.阿德福韦酯不当停药导致肝功能损伤16例分析[J].中国误诊学杂志, 2009, 9 (30) ∶7502-7503.

[8]杜以真, 张琴冈, 刘峰等.拉米夫定治疗慢性乙型肝炎停药后的复发病例分析[J].肝脏, 2004, 9 (1) ∶5-7.

[9]Honkoop P, de-Man RA, Niesters HG, et al.Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy[J].Hepatology, 2000, 32 (3) ∶635-639.

[10]慢性乙型肝炎抗病毒治疗专家共识专家委员会.慢性乙型肝炎抗病毒治疗专家共识[J].临床肝胆病杂志, 2010, 26 (2) ∶125-130.

施引文献

资源附件(0)

访问统计